Article
Brochure
Insight Hub
Executive Resource
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
With 2024 coming to a close, time is running out for manufacturing companies to take advantage of many year-end tax benefits.
The National Association of Manufacturers (NAM) conducted its Q3 Outlook Survey. Read more for a discussion and analysis of the results.
CEOs can leverage established ESG principles and best practices to create sustainable business operations and promote long-term growth.
PodcastExplore manufacturing sales and use tax exemptions with Brandon Hayes and Blake Fuqua in this Weaver: Beyond the Numbers episode.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
Discover key insights from NAM's Q2 2024 survey on manufacturing industry challenges, workforce issues and the impact of potential tax increases.
For many businesses, ASC 740 presents ongoing complexities as accounting for income taxes remains one of the most frequent drivers of restatements, control deficiencies and weaknesses due to a mixture of complex factors.
Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.
The credit is aimed at bolstering and incentivizing the emerging biotechnology sector to create jobs and invest in NYC and is available 1/1/23-1/1/26.
The quarterly survey highlights a positive outlook for companies tempered by concerns about possible taxation and regulatory pressures.
Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.